The role of adipocyte gamma-secretase in regulation of inflammatory signaling
脂肪细胞γ-分泌酶在炎症信号调节中的作用
基本信息
- 批准号:9757774
- 负责人:
- 金额:$ 12.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-07 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipocytesAdipose tissueAdultAffectAlzheimer&aposs DiseaseAwardBasic ScienceBiologyBiometryCCL2 geneCell physiologyCell surfaceCellsChildhoodChildhood diabetesClinicalComplexDataData AnalysesDevelopmentDiabetes MellitusDisease ProgressionDoctor of PhilosophyEndocrineEndocrinologyEnvironmentEpidemiologyEventExtramural ActivitiesFellowshipFoundationsFunctional disorderFundingFutureGLUT 4 proteinGLUT4 geneGap JunctionsGene ExpressionGenetic TranscriptionGoalsHealth SciencesHypersensitivityIL6 geneImmuneImmune signalingImmune systemImmunologyIn VitroInflammationInflammatoryInstructionInsulinInsulin ResistanceIntegral Membrane ProteinMacrophage ActivationMalignant NeoplasmsMediatingMedicineMentorsMetabolicMicroRNAsMultienzyme ComplexesNon-Insulin-Dependent Diabetes MellitusObesityOklahomaPTEN genePathway interactionsPatientsPediatricsPhenotypePhosphoric Monoester HydrolasesPhysiciansPlaguePlayPopulationPositioning AttributePrevalenceProcessProductionProteolysisPublic HealthPublicationsRegulationResearchResidenciesResourcesRheumatologyRoleScientistSignal PathwaySignal TransductionSocietiesStatistical Data InterpretationT-LymphocyteTREM2 geneTYROBP geneTechniquesThinnessTimeTrainingTranslationsUniversitiesWorkadipocyte differentiationalpha secretaseattenuationcareercell typeclinical practicecollegecytokinegamma secretasein vitro testinginflammatory milieuinhibitor/antagonistinsulin sensitivityknock-downmacrophagenotch proteinnovelpediatric departmentprofessorprotein expressionprotein protein interactionrecruitsecretaseskillsstatisticssymposiumtool
项目摘要
Abstract
The candidate, David P. Sparling, MD, PhD, proposes a Clinical Scientist Development Award project as a means
to achieve his goal of becoming an independent physician scientist studying the regulation of adipose tissue and
inflammation in obesity and Type 2 diabetes mellitus (T2DM). While much effort has been put into understanding the role
of inflammatory cells, e.g. macrophages and T cells, in the progression of adipose tissue insulin resistance, there should
also be a focus on the cell likely originating those inflammatory signals—namely, the adipocyte. A variety of signaling
events likely occur during the inflammatory processes in excessive adiposity, and a novel tool has been implicated to study
these processes: the -secretase enzyme complex. Signaling cascades regulating both adipose differentiation and insulin
sensitivity cascades utilize -secretase, and it plays a role in several immune signaling cascades in other cell types.
However, the function of-secretase in adipocyte-initiated inflammatory signaling is unknown. Dr. Sparling proposes that
-secretase blockade could be a tool to identify novel cascades and signaling functions in adipocyte inflammation.
Preliminary data has suggested that adipocyte-specific blockade of -secretase alters the inflammatory milieu of lean and
obese adipose tissue.
Dr. Sparling hypothesizes that -secretase is integral to adipocyte-initiated inflammatory signaling cascades,
and that this hypothesis can be tested in vitro with two specific aims. Aim 1 will determine if -secretase is required for
adipocyte-initiated macrophage recruitment and activation, and Aim 2 will determine if the immunoreceptor TREM2 in
adipocytes is regulated in a -secretase dependent manner. Dr. Sparling will first identify the role of adipocyte -secretase
in recruitment and activation of macrophages. He will identify changes in established inflammatory cytokines MCP1 and
IL6 secreted by adipocytes following -secretase inhibition. He will also explore novel targets of -secretase regulated
intramembrane proteolysis that play a role in adipocyte inflammation. He will then examine the alterations in TREM2
signaling following -secretase inhibition. TREM2 is a known -secretase target in immune cells, and can regulate adipose
function. He will determine if -secretase inhibition alters TREM2 protein-protein interactions and downstream signaling
in adipocytes. In the long term, this work seeks to establish how adipocytes regulate inflammatory signals in the
progression of obesity to T2DM.
Dr. Sparling has shown a lasting commitment to basic research and its possible translation to clinical practice. His
dissertation at the University of Oklahoma was on the transcriptional regulatory mechanisms of the insulin-responsive
glucose transporter GLUT4. After pediatrics residency at Columbia University he completed a fellowship in pediatric
endocrinology, studying the role of the Notch cascade in developed adipose tissue. This work was funded by the Endocrine
Fellows Foundation and the Pediatric Endocrine Society, and resulted in a first author publication. He accepted his position
as an Assistant Professor at the University of Oklahoma Health Sciences Center, Department of Pediatrics, in the Section
of Pediatric Diabetes and Endocrinology, where he now has protected time to begin his research career.
The basis of Dr. Sparling's work has been in adipose biology, but has now expanded to focus on inflammatory
signaling. As such, training gaps for Dr. Sparling have been identified: his understanding of immune cell function and
inflammatory regulators, as well as a need for better understanding of appropriate techniques in advanced data analysis.
To reach his goal as an independent clinician scientist studying adipose inflammation, these gaps must be addressed. The
K08 award provides an excellent means to achieve these goals. During the award Dr. Sparling will:
1) Expand his understanding of the immune system and inflammatory signaling cascades. This will primarily be
through instruction and training by his mentor, Dr. Mary Beth Humphrey, chair of the Division of
Rheumatology, Immunology, and Allergy in the Department of Medicine at OUHSC. He will also attend
graduate didactic courses in immunology, as well as immunology research conferences on campus.
2) Acquire advanced training in statistical analysis through additional statistics courses offered through the
Department of Biostatistics and Epidemiology in the College of Public Health at OUHSC.
Obesity continues to plague both pediatric and adult populations, and inflammation can play a role in insulin
resistance. What is not fully known is what degree inflammation is initiated directly by the adipocyte, and how that
signaling evolves in the progression to T2DM. The goal of this award is to develop the skills to examine how inflammatory
signals effect cross-talk between adipocytes and the immune system. The environment at the University of Oklahoma is
well suited for this work, with mentors, collaborators, and resources all available to successfully complete this project.
The training afforded by this award will prepare Dr. Sparling to seek ongoing extramural funding to continue to contribute
to the field of diabetes and endocrinology.
抽象的
候选人David P. Sparling,医学博士,博士提出了一个临床科学家开发奖项目作为手段
为了实现他的目标,即研究脂肪组织调节的独立科学家
肥胖和2型糖尿病的炎症(T2DM)。
肿瘤细胞,例如巨噬细胞和T细胞,在脂肪组织耐药性的进展中
还要关注可能源自这些炎症信号的细胞 - 即脂肪细胞。
过度肥胖的炎症过程中可能发生的事件,并暗示了一种新的工具来研究
这些过程:-分泌酶复合物。
灵敏度级联反应利用-分泌酶,并且在其他细胞类型的严重免疫免疫信号传导级联反应中起作用。
霍弗(Howver),分泌酶在脂肪细胞引起的炎症炎症信号传导中的功能尚不清楚。
-分泌酶阻断可能是识别新颖的新型级联反应和脂肪细胞炎症中的信号传导功能的工具。
初步数据表明,-分泌酶的脂肪细胞特异性封锁改变了瘦和瘦的环境
肥胖的脂肪组织。
Sparling博士的假设是-分泌酶是脂肪细胞炎性炎症信号级联反应不可或缺的
并且可以在两个特定目标中在体外测试该假设。
脂肪细胞引起的巨噬细胞募集和激活,AIM 2将确定免疫受体trem2是否在
脂肪细胞以sparling Livestly Wilst的方式定期。
在巨噬细胞的募集和激活中。
IL6被脂肪细胞分泌,-分泌酶渗入蛋白酶也将探索-分泌酶调节的新型靶标
在脂肪细胞炎症中起作用的膜内蛋白质。
-分泌酶渗透的信号传导。
功能。
在脂肪细胞中,这项工作旨在确定脂肪细胞如何调节
肥胖对T2DM的进展。
Sparling博士对基础研究表现出了持久的承诺,并可能将其转化为临床实践
俄克拉荷马大学的论文是关于胰岛素反应性的转录调节机制
葡萄糖转运蛋白GLUT4。
内分泌学,研究级联级联在发达的脂肪组织中的作用。
研究员基金会和小儿内分泌学会,并导致了第一篇作者出版物。
俄克拉荷马大学健康科学中心的屁股教授,第二次
小儿糖尿病和内分泌学,在这里保护了开始他的研究职业的时间。
Sparring博士工作的基础一直在adipse Biology中,但现在已经扩展到专注于炎症
信号。
炎症调节剂,以及在高级数据分析中更好地理解适当技术的需求。
为了达到HIL,作为对脂肪炎症的临床科学研究,这些差距必须脱粒。
K08奖提供了实现这些目标的绝佳手段。
1)扩大他对免疫系统和炎症信号级联的理解。
通过他的导师玛丽·贝丝·汉弗莱(Mary Beth Humphrey)博士的指导和培训
OUHSC医学系中的风湿病,免疫学和过敏。
免疫学的研究生教学课程以及校园的Imunology研究会议。
2)通过通过THE提供的其他统计课程获得统计分析的高级培训
OUHSC公共学院生物统计学和流行病学系。
肥胖症继续困扰小儿和成人种群,炎症可以在胰岛素中发挥作用
阻力。
信号在T2DM的进展中发展。
信号效应脂肪细胞和免疫系统之间的交叉话题。
非常适合与导师,合作者和资源一起成功完成该项目的工作。
本周提供的培训使Sparling博士准备寻求。
到糖尿病和内分泌学领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Sparling其他文献
David Sparling的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Sparling', 18)}}的其他基金
The role of adipocyte gamma-secretase in regulation of inflammatory signaling
脂肪细胞γ-分泌酶在炎症信号调节中的作用
- 批准号:
9430682 - 财政年份:2017
- 资助金额:
$ 12.47万 - 项目类别:
相似国自然基金
Acvrl1调控脂肪组织巨噬细胞M1/M2极化改善肥胖的机制研究
- 批准号:82300973
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
巨噬细胞介导脂肪组织重构在塑化剂干扰系统能量代谢中的作用研究
- 批准号:82373625
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
巨噬细胞GP73-CXCL5调节脂肪组织适应性产热的机制研究
- 批准号:32300573
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MYO9B缺失调控脂肪组织巨噬细胞代谢重编程促进肥胖相关胰岛素抵抗的机制研究
- 批准号:82300948
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
- 批准号:
10733720 - 财政年份:2023
- 资助金额:
$ 12.47万 - 项目类别:
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
- 批准号:
10619176 - 财政年份:2023
- 资助金额:
$ 12.47万 - 项目类别:
Multimodal omics approach to identify health to cardiometabolic disease transitions
多模式组学方法确定健康状况向心脏代谢疾病的转变
- 批准号:
10753664 - 财政年份:2023
- 资助金额:
$ 12.47万 - 项目类别:
Role of Pcpe2 in Adipose Tissue Remodeling and Lipoprotein Metabolism
Pcpe2 在脂肪组织重塑和脂蛋白代谢中的作用
- 批准号:
10837655 - 财政年份:2023
- 资助金额:
$ 12.47万 - 项目类别: